inguinal hernia, pos operatory pain
Conditions
Interventions
Prospective, randomized, double blind study, admitting 60 patients randomly distributed in 3 groups of 20 patients each. Group A patients (n = 20) will receive pregabalin 300mg, 1 hour before surgery
Drug
Sponsors
universidade de santo amaro
Hospital Geral do Grajaú
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Male patients, aged between 18 and 60 years, with primary unilateral inguinal hernia, without comorbidities
Exclusion criteria
Exclusion criteria: Patients on non-hormonal anti-inflammatory or corticosteroid use prior to surgery, discontinuation of medication use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate if pregabalin reduces the occurrence of chronic postoperative pain, through the method of 2 distinct dosing schedules, compared with placebo. We will observe if there is a decrease in chronic pain varying by at least 5% of the occurrence of chronic pain postoperatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| We'll observate if improvement of the quality of life of patients occure. | — |
Countries
Brazil
Contacts
Public Contactsilvio gabor
universidade de santo amaro
Outcome results
None listed